Arix Bioscience appoints Giles Kerr to board
Mr. Kerr has 36 years' experience in finance across a broad range of industrial sectors with a particular focus on life sciences.
Mr. Kerr is currently the Director of Finance at the University of Oxford, and during his tenure he has established a successful investment office.
He is also a Director of Oxford University Innovation Ltd, Adaptimmune Therapeutics plc, BTG plc, Senior plc and PayPoint plc.
Mr. Kerr was previously the Chief Financial Officer of Amersham plc, acquired by GE Healthcare in 2004, and prior to that he was a partner with Arthur Andersen in the UK.
Mr. Kerr is a Fellow of Keble College, Oxford, a graduate of the University of York and a Fellow of the Institute of Chartered Accountants in England and Wales. ■